Role of interleukin 16 in multiple myeloma.

Djordje Atanackovic; York Hildebrandt; Julia Templin; Yanran Cao; Christiane Keller; Jens Panse; Sabrina Meyer; Henrike Reinhard; Katrin Bartels; Nesrine Lajmi; Orhan Sezer; Axel R. Zander; Andreas Marx; Ria Uhlig; Jozef Zustin; Carsten Bokemeyer; Nicolaus Kröger

Role of interleukin 16 in multiple myeloma.

Standard

Role of interleukin 16 in multiple myeloma. / Atanackovic, Djordje; Hildebrandt, York; Templin, Julia; Cao, Yanran; Keller, Christiane; Panse, Jens; Meyer, Sabrina; Reinhard, Henrike; Bartels, Katrin; Lajmi, Nesrine; Sezer, Orhan; Zander, Axel R.; Marx, Andreas; Uhlig, Ria; Zustin, Jozef; Bokemeyer, Carsten ; Kröger, Nicolaus.

In: JNCI-J NATL CANCER I, Vol. 104, No. 13, 13, 2012, p. 1005-1020.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Atanackovic, D, Hildebrandt, Y, Templin, J, Cao, Y, Keller, C, Panse, J, Meyer, S, Reinhard, H, Bartels, K, Lajmi, N, Sezer, O, Zander, AR, Marx, A, Uhlig, R, Zustin, J, Bokemeyer, C & Kröger, N 2012, 'Role of interleukin 16 in multiple myeloma.', JNCI-J NATL CANCER I, vol. 104, no. 13, 13, pp. 1005-1020. <http://www.ncbi.nlm.nih.gov/pubmed/22745469?dopt=Citation>

APA

Atanackovic, D., Hildebrandt, Y., Templin, J., Cao, Y., Keller, C., Panse, J., Meyer, S., Reinhard, H., Bartels, K., Lajmi, N., Sezer, O., Zander, A. R., Marx, A., Uhlig, R., Zustin, J., Bokemeyer, C., & Kröger, N. (2012). Role of interleukin 16 in multiple myeloma. JNCI-J NATL CANCER I, 104(13), 1005-1020. [13]. http://www.ncbi.nlm.nih.gov/pubmed/22745469?dopt=Citation

Vancouver

Atanackovic D, Hildebrandt Y, Templin J, Cao Y, Keller C, Panse J et al. Role of interleukin 16 in multiple myeloma. JNCI-J NATL CANCER I. 2012;104(13):1005-1020. 13.

Bibtex

@article{c4b7b03e0dab464d9e29d0501d86c603,

title = "Role of interleukin 16 in multiple myeloma.",

abstract = "Multiple myeloma is a malignancy characterized by the expansion of a plasma cell clone that localizes to the human bone marrow. Myeloma cells and bone marrow stromal cells produce soluble factors that promote the survival and progression of multiple myeloma. Interleukin 16 (IL-16) is involved in regulating the migration and proliferation of normal leukocytes. However, the role of IL-16 in human cancers, including multiple myeloma, is unclear.",

keywords = "Adult, Humans, Male, Aged, Female, Middle Aged, Immunohistochemistry, Up-Regulation, Apoptosis, Reverse Transcriptase Polymerase Chain Reaction, Cell Line, Tumor, Gene Expression Regulation, Neoplastic, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Cell Proliferation, Gene Silencing, Neoplastic Stem Cells/metabolism, Antigens, CD4/metabolism, Antigens, CD9/metabolism, Bone Marrow Cells/*metabolism, Interleukin-6/*genetics/*metabolism, Multiple Myeloma/*metabolism, Plasma Cells/*metabolism, RNA, Small Interfering/metabolism, Adult, Humans, Male, Aged, Female, Middle Aged, Immunohistochemistry, Up-Regulation, Apoptosis, Reverse Transcriptase Polymerase Chain Reaction, Cell Line, Tumor, Gene Expression Regulation, Neoplastic, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Cell Proliferation, Gene Silencing, Neoplastic Stem Cells/metabolism, Antigens, CD4/metabolism, Antigens, CD9/metabolism, Bone Marrow Cells/*metabolism, Interleukin-6/*genetics/*metabolism, Multiple Myeloma/*metabolism, Plasma Cells/*metabolism, RNA, Small Interfering/metabolism",

author = "Djordje Atanackovic and York Hildebrandt and Julia Templin and Yanran Cao and Christiane Keller and Jens Panse and Sabrina Meyer and Henrike Reinhard and Katrin Bartels and Nesrine Lajmi and Orhan Sezer and Zander, {Axel R.} and Andreas Marx and Ria Uhlig and Jozef Zustin and Carsten Bokemeyer and Nicolaus Kr{\"o}ger",

year = "2012",

language = "English",

volume = "104",

pages = "1005--1020",

journal = "JNCI-J NATL CANCER I",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "13",

}

RIS

TY - JOUR

T1 - Role of interleukin 16 in multiple myeloma.

AU - Atanackovic, Djordje

AU - Hildebrandt, York

AU - Templin, Julia

AU - Cao, Yanran

AU - Keller, Christiane

AU - Panse, Jens

AU - Meyer, Sabrina

AU - Reinhard, Henrike

AU - Bartels, Katrin

AU - Lajmi, Nesrine

AU - Sezer, Orhan

AU - Zander, Axel R.

AU - Marx, Andreas

AU - Uhlig, Ria

AU - Zustin, Jozef

AU - Bokemeyer, Carsten

AU - Kröger, Nicolaus

PY - 2012

Y1 - 2012

N2 - Multiple myeloma is a malignancy characterized by the expansion of a plasma cell clone that localizes to the human bone marrow. Myeloma cells and bone marrow stromal cells produce soluble factors that promote the survival and progression of multiple myeloma. Interleukin 16 (IL-16) is involved in regulating the migration and proliferation of normal leukocytes. However, the role of IL-16 in human cancers, including multiple myeloma, is unclear.

AB - Multiple myeloma is a malignancy characterized by the expansion of a plasma cell clone that localizes to the human bone marrow. Myeloma cells and bone marrow stromal cells produce soluble factors that promote the survival and progression of multiple myeloma. Interleukin 16 (IL-16) is involved in regulating the migration and proliferation of normal leukocytes. However, the role of IL-16 in human cancers, including multiple myeloma, is unclear.

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Immunohistochemistry

KW - Up-Regulation

KW - Apoptosis

KW - Reverse Transcriptase Polymerase Chain Reaction

KW - Cell Line, Tumor

KW - Gene Expression Regulation, Neoplastic

KW - Enzyme-Linked Immunosorbent Assay

KW - Flow Cytometry

KW - Cell Proliferation

KW - Gene Silencing

KW - Neoplastic Stem Cells/metabolism

KW - Antigens, CD4/metabolism

KW - Antigens, CD9/metabolism

KW - Bone Marrow Cells/metabolism

KW - Interleukin-6/genetics/metabolism

KW - Multiple Myeloma/metabolism

KW - Plasma Cells/metabolism

KW - RNA, Small Interfering/metabolism